0001385508-21-000013.txt : 20210127 0001385508-21-000013.hdr.sgml : 20210127 20210127161308 ACCESSION NUMBER: 0001385508-21-000013 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20210126 FILED AS OF DATE: 20210127 DATE AS OF CHANGE: 20210127 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Skolnick Phil CENTRAL INDEX KEY: 0001358116 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-38193 FILM NUMBER: 21559868 MAIL ADDRESS: STREET 1: C/O DOV PHARMACEUTICAL, INC. STREET 2: 433 HACKENSACK AVENUE CITY: HACKENSACK STATE: NJ ZIP: 07601 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: OPIANT PHARMACEUTICALS, INC. CENTRAL INDEX KEY: 0001385508 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 000000000 STATE OF INCORPORATION: NV FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 201 SANTA MONICA BOULEVARD STREET 2: SUITE 500 CITY: SANTA MONICA STATE: CA ZIP: 90401 BUSINESS PHONE: (310) 598-5410 MAIL ADDRESS: STREET 1: 201 SANTA MONICA BOULEVARD STREET 2: SUITE 500 CITY: SANTA MONICA STATE: CA ZIP: 90401 FORMER COMPANY: FORMER CONFORMED NAME: Lightlake Therapeutics Inc. DATE OF NAME CHANGE: 20091009 FORMER COMPANY: FORMER CONFORMED NAME: Madrona Ventures, Inc. DATE OF NAME CHANGE: 20070108 4 1 wf-form4_161178197585449.xml FORM 4 X0306 4 2021-01-26 0 0001385508 OPIANT PHARMACEUTICALS, INC. OPNT 0001358116 Skolnick Phil C/O OPIANT PHARMACEUTICALS, INC. 233 WILSHIRE BLVD., SUITE 280 SANTA MONICA CA 90401 0 1 0 0 Chief Scientific Officer Common Stock 2021-01-26 4 A 0 2798 0 A 6948 D Common Stock 2021-01-26 4 A 0 5400 0 A 12348 D Stock Option (right to buy) 12.15 2021-01-26 4 A 0 10750 0 A 2031-01-26 Common Stock 10750.0 10750 D 2,798 shares are represented by restricted stock units ("RSUs"). Each RSU represents the Reporting Person's right to receive one share of Common Stock of Issuer, subject to the vesting schedule. 100% of the RSUs vest on the anniversary date of January 26, 2022, subject to the Reporting Person continuing as a service provider through each such date. 5,400 shares are represented by restricted stock units ("RSUs"). Each RSU represents the Reporting Person's right to receive one share of Common Stock of Issuer, subject to the vesting schedule. One-fourth of the RSUs vest on the anniversary dates of January 26, 2022, January 26, 2023, January 6, 2024 and January 26, 2025, subject to the Reporting Person continuing as a service provider through each such date. On January 26, 2021, the reporting person was granted an option to purchase 10,750 shares of common stock. The option vests as follows: 1/48 of the options become exercisable on the first monthly anniversary of January 26, 2021, the vesting commencement date, and 1/48 of the options become exercisable on such date every month thereafter through the fourth year anniversary of the vesting commencement date. /s/ Phil Skolnick 2021-01-27